Want to see NUTX full AI Analyst Report?
Total Valuation
Clinigence Holdings has a market cap or net worth of $1.27B. The enterprise value is $1.45K.
Market Cap$1.27B
Enterprise Value$1.45K
Share Statistics
Clinigence Holdings has 6,847,973 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,847,973
Owned by Insiders32.77%
Owned by Institutions10.24%
Financial Efficiency
Clinigence Holdings’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 25.91%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)25.91%
Return on Capital Employed (ROCE)0.36
Revenue Per Employee844.03K
Profits Per Employee173.92K
Employee Count1,037
Asset Turnover0.95
Inventory Turnover150.38
Valuation Ratios
The current PE Ratio of Clinigence Holdings is 7.1. Clinigence Holdings’s PEG ratio is 1.68.
PE Ratio7.1
PS Ratio1.20
PB Ratio3.18
Price to Fair Value3.18
Price to FCF4.26
Price to Operating Cash Flow4.45
PEG Ratio1.68
Income Statement
In the last 12 months, Clinigence Holdings had revenue of 875.26M and earned 70.79M in profits. Earnings per share was 11.13.
Revenue875.26M
Gross Profit444.28M
Operating Income275.63M
Pretax Income244.78M
Net Income70.79M
EBITDA287.54M
Earnings Per Share (EPS)11.13
Cash Flow
In the last 12 months, operating cash flow was 279.62M and capital expenditures -5.45M, giving a free cash flow of 274.17M billion.
Operating Cash Flow279.62M
Free Cash Flow274.17M
Free Cash Flow per Share40.04
Dividends & Yields
Clinigence Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.13
52-Week Price Change107.62%
50-Day Moving Average166.18
200-Day Moving Average137.39
Relative Strength Index (RSI)58.16
Average Volume (3m)120.76K
Important Dates
Clinigence Holdings upcoming earnings date is Nov 24, 2026, After Close (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 24, 2026
Ex-Dividend Date―
Financial Position
Clinigence Holdings as a current ratio of 3.41, with Debt / Equity ratio of 88.09%
Current Ratio3.41
Quick Ratio3.39
Debt to Market Cap0.04
Net Debt to EBITDA0.58
Interest Coverage Ratio12.40
Taxes
In the past 12 months, Clinigence Holdings has paid 64.42M in taxes.
Income Tax64.42M
Effective Tax Rate0.26
Enterprise Valuation
Clinigence Holdings EV to EBITDA ratio is 4.22, with an EV/FCF ratio of 4.94.
EV to Sales1.39
EV to EBITDA4.22
EV to Free Cash Flow4.94
EV to Operating Cash Flow4.89
Balance Sheet
Clinigence Holdings has $205.21M in cash and marketable securities with $347.34M in debt, giving a net cash position of -$142.13M billion.
Cash & Marketable Securities$205.21M
Total Debt$347.34M
Net Cash-$142.13M
Net Cash Per Share-$20.75
Tangible Book Value Per Share$61.04
Margins
Gross margin is 51.26%, with operating margin of 31.49%, and net profit margin of 8.09%.
Gross Margin51.26%
Operating Margin31.49%
Pretax Margin27.97%
Net Profit Margin8.09%
EBITDA Margin32.85%
EBIT Margin30.51%
Analyst Forecast
The average price target for Clinigence Holdings is $266.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$266.67
Price Target Upside82.81% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast6.88%
EPS Growth Forecast155.98%